Deborah Siegal/LinkedIn
Mar 1, 2026, 10:31
Deborah Siegal Explores ARTESiA in The CLOT Conversation’s Latest Episode
Thrombosis Canada shared on LinkedIn:
”Major bleeding remains the leading complication of oral anticoagulation.
In our latest episode of CLOT Conversations, Dr. Deborah Siegal discusses the ARTESiA subanalysis examining major bleeding with apixaban versus aspirin in patients with device-detected subclinical atrial fibrillation.
Key insights:
- Apixaban reduced stroke/systemic embolism by 37%
- Major bleeding increased, largely driven by gastrointestinal events
- Intracranial and fatal bleeding rates were low and similar
- Most bleeding events were not clinical emergencies
- NSAID use emerged as a key modifiable risk factor
Understanding not just how often bleeding occurs, but how severe it is, is critical to individualized risk assessment and shared decision-making.”
Stay updated with Hemostasis Today.
-
Apr 15, 2026, 13:51Matías J Alet: Hospital Carlos Saporiti on the Path to Essential Stroke Center Recognition
-
Apr 15, 2026, 13:39Congratulations to Sandy Middleton for Taking the 2026 HESTA Australian Nursing and Midwifery Awards – Stroke Foundation
-
Apr 15, 2026, 13:25Wolfgang Miesbach: Platelet Variation and How Do They Move Over Time?
-
Apr 15, 2026, 12:44Marwa Elnahas: 4Ts Scoring Tool for Heparin – Induced Thrombocytopenia
-
Apr 15, 2026, 12:27Laurent Bertoletti: Joining Global Experts to Improve Thrombosis Care in Cancer for the ICTHIC 16th Edition
-
Apr 15, 2026, 12:13Francesco Antonio Veneziano: JCDD MDPI Calls for Papers on Advances in Thrombosis and Antithrombotic Therapy
-
Apr 15, 2026, 11:05Julius Kyei Baffour: Understanding Thrombophilia Testing and Patient Risk
-
Apr 15, 2026, 09:10Shall I Bleed Less with Age? Just 2 Weeks Until the Webinar – EHC
-
Apr 15, 2026, 08:51Moustafa Abdou: Sutimlimab is Transforming Outcomes in Cold Agglutinin Disease